Press Releases

STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial planning for a market entry in Japan.

NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its pr

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against Novartis AG (NASDAQ: NVS) on behalf of Novartis investors. Our investigation concerns whether Novartis has violated the federal securities laws and/or engaged in other unlawful business practices.

LOS ANGELES, Aug. 8, 2019 /PRNewswire/ -- Adnant, an accounting and consulting firm, is hosting a networking event at Outside Lands that will bring together top cannabis brands, executives and investors. Outside Lands takes place in San Francisco's Golden Gate Park from August 9-11, 2019. The festival i

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Corindus Vascular Robotics, Inc. (NYSE: CVRS) on behalf of Corindus shareholders concerning the proposed merger with a subsidiary of Siemens Healthineers AG.

CHICAGO, Aug. 8, 2019 /PRNewswire/ -- Gun violence in the United States is a public health crisis and should be addressed much as the government studies motor vehicle deaths, according to the president of the American Psychological Association.

In the news release, Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update, issued 08-Aug-2019 by Achieve Life Sciences, Inc. over PR Newswire, we are advised by the company that the column headers in the Consolidated Statements of Loss table have been updated. The complete, corrected release follows:Achieve Reports Financial Results fo

MARIETTA, Ga., Aug. 8, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced an agreement with the plaintiff (the "Plaintiff") in the matter City of Hialeah Employees' Retirement System v. MiMedx Group, Inc. As has been previous

FLINT, Mich., Aug. 8, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency,

WINNIPEG, Aug. 8, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter ended June 30, 2019.  Quarter Ended June 30, 2019 Highlights: